Shares of Jaguar Health Inc (NASDAQ:JAGX) traded up 15.4% on Wednesday . The company traded as high as $0.33 and last traded at $0.28. 21,696,699 shares were traded during mid-day trading, an increase of 363% from the average session volume of 4,682,525 shares. The stock had previously closed at $0.24.

Separately, ValuEngine lowered shares of Jaguar Health from a “buy” rating to a “hold” rating in a research report on Thursday, January 24th.

The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.31 and a current ratio of 0.46.

TRADEMARK VIOLATION NOTICE: This piece was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at

Jaguar Health Company Profile (NASDAQ:JAGX)

Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Featured Article: What is the LIBOR?

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with's FREE daily email newsletter.